vs
Side-by-side financial comparison of T Stamp Inc (IDAI) and Insight Molecular Diagnostics Inc. (IMDX). Click either name above to swap in a different company.
Insight Molecular Diagnostics Inc. is the larger business by last-quarter revenue ($1.1M vs $908.9K, roughly 1.3× T Stamp Inc). T Stamp Inc runs the higher net margin — -279.9% vs -2015.4%, a 1735.5% gap on every dollar of revenue. On growth, Insight Molecular Diagnostics Inc. posted the faster year-over-year revenue change (-23.4% vs -39.3%). T Stamp Inc produced more free cash flow last quarter ($2.0M vs $-7.0M). Over the past eight quarters, Insight Molecular Diagnostics Inc.'s revenue compounded faster (154.4% CAGR vs 25.9%).
T Stamp Inc, trading under ticker IDAI, develops AI-powered identity verification, trust scoring, and fraud prevention solutions. It serves clients across fintech, healthcare, and e-commerce segments, primarily operating in North America to help organizations securely authenticate user identities and mitigate fraud risks.
Quest Diagnostics Incorporated is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.
IDAI vs IMDX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $908.9K | $1.1M |
| Net Profit | $-2.5M | $-23.0M |
| Gross Margin | — | 42.5% |
| Operating Margin | -224.9% | -2057.5% |
| Net Margin | -279.9% | -2015.4% |
| Revenue YoY | -39.3% | -23.4% |
| Net Profit YoY | 57.7% | 31.5% |
| EPS (diluted) | $-0.37 | $-0.75 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $908.9K | $1.1M | ||
| Q3 25 | $872.5K | $260.0K | ||
| Q2 25 | $812.7K | $518.0K | ||
| Q1 25 | $545.5K | $2.1M | ||
| Q4 24 | $1.5M | $1.5M | ||
| Q3 24 | $511.1K | $115.0K | ||
| Q2 24 | $500.4K | $104.0K | ||
| Q1 24 | $573.7K | $176.0K |
| Q4 25 | $-2.5M | $-23.0M | ||
| Q3 25 | $-1.9M | $-10.9M | ||
| Q2 25 | $-1.7M | $-9.7M | ||
| Q1 25 | $-2.2M | $-6.7M | ||
| Q4 24 | $-6.0M | $-33.5M | ||
| Q3 24 | $-1.3M | $-13.5M | ||
| Q2 24 | $-2.6M | $-4.5M | ||
| Q1 24 | $-2.7M | $-9.1M |
| Q4 25 | — | 42.5% | ||
| Q3 25 | — | 53.5% | ||
| Q2 25 | — | 67.6% | ||
| Q1 25 | — | 62.0% | ||
| Q4 24 | — | 40.0% | ||
| Q3 24 | — | 43.5% | ||
| Q2 24 | — | 48.1% | ||
| Q1 24 | — | 25.6% |
| Q4 25 | -224.9% | -2057.5% | ||
| Q3 25 | -203.0% | -4249.2% | ||
| Q2 25 | -207.0% | -1900.0% | ||
| Q1 25 | -396.5% | -318.0% | ||
| Q4 24 | -81.2% | -2262.9% | ||
| Q3 24 | -523.7% | -11752.2% | ||
| Q2 24 | -524.7% | -4453.8% | ||
| Q1 24 | -496.7% | -5265.3% |
| Q4 25 | -279.9% | -2015.4% | ||
| Q3 25 | -219.1% | -4174.6% | ||
| Q2 25 | -210.7% | -1880.7% | ||
| Q1 25 | -395.5% | -312.0% | ||
| Q4 24 | -401.5% | -2255.1% | ||
| Q3 24 | -245.7% | -11733.0% | ||
| Q2 24 | -519.3% | -4355.8% | ||
| Q1 24 | -466.9% | -5186.9% |
| Q4 25 | $-0.37 | $-0.75 | ||
| Q3 25 | $-0.72 | $-0.34 | ||
| Q2 25 | $-0.69 | $-0.30 | ||
| Q1 25 | $-0.89 | $-0.26 | ||
| Q4 24 | $-3.14 | $-2.19 | ||
| Q3 24 | $-1.06 | $-0.98 | ||
| Q2 24 | $-3.19 | $-0.36 | ||
| Q1 24 | $-3.97 | $-1.13 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $6.0M | $11.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $8.7M | $-31.5M |
| Total Assets | $11.2M | $25.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $6.0M | $11.6M | ||
| Q3 25 | $5.4M | $18.7M | ||
| Q2 25 | $292.1K | $24.3M | ||
| Q1 25 | $1.1M | $31.0M | ||
| Q4 24 | $2.8M | $8.6M | ||
| Q3 24 | $598.0K | $3.4M | ||
| Q2 24 | $659.5K | $9.3M | ||
| Q1 24 | $816.7K | $5.6M |
| Q4 25 | $8.7M | $-31.5M | ||
| Q3 25 | $6.1M | $-9.2M | ||
| Q2 25 | $2.4M | $1.1M | ||
| Q1 25 | $4.1M | $10.2M | ||
| Q4 24 | $3.0M | $-12.3M | ||
| Q3 24 | $5.4M | $9.7M | ||
| Q2 24 | $750.4K | $22.7M | ||
| Q1 24 | $1.4M | $11.6M |
| Q4 25 | $11.2M | $25.8M | ||
| Q3 25 | $11.2M | $43.9M | ||
| Q2 25 | $5.7M | $50.5M | ||
| Q1 25 | $6.6M | $60.4M | ||
| Q4 24 | $8.6M | $35.1M | ||
| Q3 24 | $10.6M | $70.2M | ||
| Q2 24 | $5.2M | $74.7M | ||
| Q1 24 | $5.6M | $71.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $2.0M | $-5.5M |
| Free Cash FlowOCF − Capex | $2.0M | $-7.0M |
| FCF MarginFCF / Revenue | 215.4% | -616.7% |
| Capex IntensityCapex / Revenue | 0.8% | 129.9% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-5.7M | $-25.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $2.0M | $-5.5M | ||
| Q3 25 | $-4.0M | $-4.5M | ||
| Q2 25 | $-2.1M | $-6.3M | ||
| Q1 25 | $-1.5M | $-5.9M | ||
| Q4 24 | $-2.7M | $-5.4M | ||
| Q3 24 | $-2.4M | $-5.5M | ||
| Q2 24 | $-1.6M | $-6.0M | ||
| Q1 24 | $-2.2M | $-3.8M |
| Q4 25 | $2.0M | $-7.0M | ||
| Q3 25 | $-4.0M | $-5.6M | ||
| Q2 25 | $-2.1M | $-6.6M | ||
| Q1 25 | $-1.6M | $-6.2M | ||
| Q4 24 | $-2.7M | $-5.6M | ||
| Q3 24 | $-2.4M | $-5.6M | ||
| Q2 24 | $-1.6M | $-6.2M | ||
| Q1 24 | $-2.2M | $-3.9M |
| Q4 25 | 215.4% | -616.7% | ||
| Q3 25 | -459.6% | -2135.4% | ||
| Q2 25 | -258.6% | -1279.5% | ||
| Q1 25 | -289.2% | -288.4% | ||
| Q4 24 | -182.9% | -374.5% | ||
| Q3 24 | -475.4% | -4884.3% | ||
| Q2 24 | -320.9% | -5931.7% | ||
| Q1 24 | -376.6% | -2189.8% |
| Q4 25 | 0.8% | 129.9% | ||
| Q3 25 | 0.0% | 403.8% | ||
| Q2 25 | 0.2% | 67.4% | ||
| Q1 25 | 6.8% | 14.4% | ||
| Q4 24 | 0.1% | 14.4% | ||
| Q3 24 | 0.7% | 75.7% | ||
| Q2 24 | 1.3% | 183.7% | ||
| Q1 24 | 0.5% | 13.6% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
